nodes	percent_of_prediction	percent_of_DWPC	metapath
Goserelin—LHCGR—Peptide GPCRs—CCR9—Crohn's disease	0.0198	0.0546	CbGpPWpGaD
Goserelin—LHCGR—Ovarian Infertility Genes—SMAD3—Crohn's disease	0.0145	0.0401	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR9—Crohn's disease	0.0132	0.0365	CbGpPWpGaD
Goserelin—LHCGR—Peptide GPCRs—CCR6—Crohn's disease	0.0131	0.0362	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—ACKR2—Crohn's disease	0.0111	0.0306	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00948	0.0262	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—MLN—Crohn's disease	0.00909	0.0251	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00899	0.0248	CbGpPWpGaD
Goserelin—GNRHR—Peptide GPCRs—CCR6—Crohn's disease	0.00876	0.0242	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—MLN—Crohn's disease	0.00813	0.0225	CbGpPWpGaD
Goserelin—LHCGR—G alpha (s) signalling events—PTGER4—Crohn's disease	0.00762	0.0211	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR9—Crohn's disease	0.00727	0.0201	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—ACKR2—Crohn's disease	0.00722	0.02	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—MLN—Crohn's disease	0.00685	0.0189	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—GPR65—Crohn's disease	0.00676	0.0187	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR2—Crohn's disease	0.00635	0.0175	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00623	0.0172	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—MLN—Crohn's disease	0.00602	0.0166	CbGpPWpGaD
Goserelin—GNRHR—G alpha (q) signalling events—GPR65—Crohn's disease	0.00586	0.0162	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00579	0.016	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—GPR65—Crohn's disease	0.00524	0.0145	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—ACKR2—Crohn's disease	0.00483	0.0134	CbGpPWpGaD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—CCR6—Crohn's disease	0.00482	0.0133	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—CCR9—Crohn's disease	0.00474	0.0131	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—MLN—Crohn's disease	0.00458	0.0127	CbGpPWpGaD
Goserelin—LHCGR—GPCR ligand binding—GPR65—Crohn's disease	0.00441	0.0122	CbGpPWpGaD
Goserelin—Cough increased—Mesalazine—Crohn's disease	0.00426	0.00668	CcSEcCtD
Goserelin—LHCGR—GPCRs, Class A Rhodopsin-like—PTGER4—Crohn's disease	0.00424	0.0117	CbGpPWpGaD
Goserelin—Gout—Mesalazine—Crohn's disease	0.00418	0.00655	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR9—Crohn's disease	0.00417	0.0115	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00413	0.0114	CbGpPWpGaD
Goserelin—Vaginal inflammation—Mesalazine—Crohn's disease	0.0039	0.00612	CcSEcCtD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—GPR65—Crohn's disease	0.00388	0.0107	CbGpPWpGaD
Goserelin—Neoplasm—Azathioprine—Crohn's disease	0.00387	0.00607	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—MLN—Crohn's disease	0.00387	0.0107	CbGpPWpGaD
Goserelin—Cystitis noninfective—Mesalazine—Crohn's disease	0.00381	0.00597	CcSEcCtD
Goserelin—Cystitis—Mesalazine—Crohn's disease	0.00377	0.00591	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—ACKR2—Crohn's disease	0.00371	0.0102	CbGpPWpGaD
Goserelin—Vaginal infection—Mesalazine—Crohn's disease	0.00368	0.00577	CcSEcCtD
Goserelin—Osteoporosis—Prednisone—Crohn's disease	0.00368	0.00577	CcSEcCtD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00363	0.01	CbGpPWpGaD
Goserelin—Dry eye—Mesalazine—Crohn's disease	0.0036	0.00565	CcSEcCtD
Goserelin—Cramps of lower extremities—Mesalazine—Crohn's disease	0.00358	0.00562	CcSEcCtD
Goserelin—Hepatic function abnormal—Azathioprine—Crohn's disease	0.00356	0.00558	CcSEcCtD
Goserelin—Multiple fractures—Prednisone—Crohn's disease	0.00355	0.00557	CcSEcCtD
Goserelin—Hirsutism—Prednisone—Crohn's disease	0.00355	0.00557	CcSEcCtD
Goserelin—Fracture—Prednisone—Crohn's disease	0.00355	0.00557	CcSEcCtD
Goserelin—Ecchymosis—Mesalazine—Crohn's disease	0.00353	0.00553	CcSEcCtD
Goserelin—Bladder pain—Mesalazine—Crohn's disease	0.00353	0.00553	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—MLN—Crohn's disease	0.00351	0.00971	CbGpPWpGaD
Goserelin—Febrile neutropenia—Prednisone—Crohn's disease	0.00343	0.00538	CcSEcCtD
Goserelin—Hypertonia—Mesalazine—Crohn's disease	0.00342	0.00536	CcSEcCtD
Goserelin—Immune system disorder—Mercaptopurine—Crohn's disease	0.00326	0.00511	CcSEcCtD
Goserelin—Alopecia—Mercaptopurine—Crohn's disease	0.00319	0.005	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CCR9—Crohn's disease	0.00318	0.00878	CbGpPWpGaD
Goserelin—Malnutrition—Mercaptopurine—Crohn's disease	0.00314	0.00493	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CCR6—Crohn's disease	0.00314	0.00868	CbGpPWpGaD
Goserelin—Libido decreased—Mesalazine—Crohn's disease	0.00305	0.00479	CcSEcCtD
Goserelin—GNRHR—G alpha (q) signalling events—RASGRP1—Crohn's disease	0.00303	0.00836	CbGpPWpGaD
Goserelin—Increased appetite—Mesalazine—Crohn's disease	0.00302	0.00473	CcSEcCtD
Goserelin—Thirst—Mesalazine—Crohn's disease	0.00298	0.00466	CcSEcCtD
Goserelin—Renal impairment—Mesalazine—Crohn's disease	0.00298	0.00466	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—GPR65—Crohn's disease	0.00295	0.00816	CbGpPWpGaD
Goserelin—Anaemia—Mercaptopurine—Crohn's disease	0.00291	0.00455	CcSEcCtD
Goserelin—Lethargy—Mesalazine—Crohn's disease	0.00289	0.00453	CcSEcCtD
Goserelin—Osteoarthritis—Mesalazine—Crohn's disease	0.00283	0.00444	CcSEcCtD
Goserelin—Leukopenia—Mercaptopurine—Crohn's disease	0.00281	0.00441	CcSEcCtD
Goserelin—Disturbance in sexual arousal—Mesalazine—Crohn's disease	0.00281	0.0044	CcSEcCtD
Goserelin—Affect lability—Mesalazine—Crohn's disease	0.00279	0.00437	CcSEcCtD
Goserelin—Migraine—Mesalazine—Crohn's disease	0.00279	0.00437	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—PTGER4—Crohn's disease	0.00277	0.00765	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR6—Crohn's disease	0.00276	0.00763	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—RASGRP1—Crohn's disease	0.00271	0.00748	CbGpPWpGaD
Goserelin—Mood swings—Mesalazine—Crohn's disease	0.00268	0.00421	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CCR9—Crohn's disease	0.00268	0.00741	CbGpPWpGaD
Goserelin—Arthralgia—Mercaptopurine—Crohn's disease	0.00268	0.00419	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00266	0.00416	CcSEcCtD
Goserelin—Dry skin—Mesalazine—Crohn's disease	0.0026	0.00407	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—MLN—Crohn's disease	0.00259	0.00716	CbGpPWpGaD
Goserelin—Oedema—Mercaptopurine—Crohn's disease	0.00257	0.00402	CcSEcCtD
Goserelin—Breast disorder—Mesalazine—Crohn's disease	0.00256	0.00401	CcSEcCtD
Goserelin—Thrombocytopenia—Mercaptopurine—Crohn's disease	0.00251	0.00394	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—GPR65—Crohn's disease	0.00249	0.00689	CbGpPWpGaD
Goserelin—Skin disorder—Mercaptopurine—Crohn's disease	0.00249	0.0039	CcSEcCtD
Goserelin—Endocrine disorder—Prednisone—Crohn's disease	0.00249	0.0039	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—ACKR2—Crohn's disease	0.00248	0.00685	CbGpPWpGaD
Goserelin—Acne—Prednisone—Crohn's disease	0.00245	0.00385	CcSEcCtD
Goserelin—Influenza—Mesalazine—Crohn's disease	0.00245	0.00384	CcSEcCtD
Goserelin—Anorexia—Mercaptopurine—Crohn's disease	0.00245	0.00383	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCR9—Crohn's disease	0.00243	0.00673	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.00243	0.00672	CbGpPWpGaD
Goserelin—Pneumonia—Azathioprine—Crohn's disease	0.00241	0.00378	CcSEcCtD
Goserelin—Angina pectoris—Mesalazine—Crohn's disease	0.00238	0.00374	CcSEcCtD
Goserelin—Bronchitis—Mesalazine—Crohn's disease	0.00235	0.00369	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—MLN—Crohn's disease	0.00235	0.0065	CbGpPWpGaD
Goserelin—Amenorrhoea—Prednisone—Crohn's disease	0.00235	0.00368	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Mercaptopurine—Crohn's disease	0.00234	0.00366	CcSEcCtD
Goserelin—Dysuria—Mesalazine—Crohn's disease	0.00229	0.00359	CcSEcCtD
Goserelin—Upper respiratory tract infection—Mesalazine—Crohn's disease	0.00228	0.00357	CcSEcCtD
Goserelin—Arthropathy—Prednisone—Crohn's disease	0.00227	0.00356	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—GPR65—Crohn's disease	0.00226	0.00625	CbGpPWpGaD
Goserelin—Pollakiuria—Mesalazine—Crohn's disease	0.00226	0.00354	CcSEcCtD
Goserelin—Photosensitivity reaction—Mesalazine—Crohn's disease	0.00223	0.0035	CcSEcCtD
Goserelin—Decreased appetite—Mercaptopurine—Crohn's disease	0.00223	0.00349	CcSEcCtD
Goserelin—Weight increased—Mesalazine—Crohn's disease	0.00223	0.00349	CcSEcCtD
Goserelin—Pneumonia—Mesalazine—Crohn's disease	0.0022	0.00344	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—ACKR2—Crohn's disease	0.00219	0.00605	CbGpPWpGaD
Goserelin—Hypercholesterolaemia—Prednisone—Crohn's disease	0.00218	0.00342	CcSEcCtD
Goserelin—Ulcer—Prednisone—Crohn's disease	0.00218	0.00342	CcSEcCtD
Goserelin—Depression—Mesalazine—Crohn's disease	0.00218	0.00341	CcSEcCtD
Goserelin—Haemoglobin—Azathioprine—Crohn's disease	0.00216	0.00339	CcSEcCtD
Goserelin—Haemorrhage—Azathioprine—Crohn's disease	0.00215	0.00337	CcSEcCtD
Goserelin—Renal failure—Mesalazine—Crohn's disease	0.00215	0.00336	CcSEcCtD
Goserelin—Jaundice—Mesalazine—Crohn's disease	0.00213	0.00333	CcSEcCtD
Goserelin—Urinary tract infection—Mesalazine—Crohn's disease	0.00212	0.00333	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—CCR6—Crohn's disease	0.0021	0.00581	CbGpPWpGaD
Goserelin—Sweating—Mesalazine—Crohn's disease	0.00209	0.00328	CcSEcCtD
Goserelin—Haematuria—Mesalazine—Crohn's disease	0.00208	0.00326	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—MLN—Crohn's disease	0.00208	0.00573	CbGpPWpGaD
Goserelin—Epistaxis—Mesalazine—Crohn's disease	0.00206	0.00323	CcSEcCtD
Goserelin—Sinusitis—Mesalazine—Crohn's disease	0.00205	0.00321	CcSEcCtD
Goserelin—Body temperature increased—Mercaptopurine—Crohn's disease	0.00203	0.00318	CcSEcCtD
Goserelin—Haemoglobin—Mesalazine—Crohn's disease	0.00197	0.00309	CcSEcCtD
Goserelin—Rhinitis—Mesalazine—Crohn's disease	0.00196	0.00308	CcSEcCtD
Goserelin—Haemorrhage—Mesalazine—Crohn's disease	0.00196	0.00307	CcSEcCtD
Goserelin—Hepatitis—Mesalazine—Crohn's disease	0.00196	0.00307	CcSEcCtD
Goserelin—Pharyngitis—Mesalazine—Crohn's disease	0.00194	0.00305	CcSEcCtD
Goserelin—Immune system disorder—Azathioprine—Crohn's disease	0.00194	0.00305	CcSEcCtD
Goserelin—Urinary tract disorder—Mesalazine—Crohn's disease	0.00194	0.00303	CcSEcCtD
Goserelin—Oedema peripheral—Mesalazine—Crohn's disease	0.00193	0.00303	CcSEcCtD
Goserelin—Chills—Azathioprine—Crohn's disease	0.00193	0.00303	CcSEcCtD
Goserelin—Arrhythmia—Azathioprine—Crohn's disease	0.00192	0.00301	CcSEcCtD
Goserelin—Urethral disorder—Mesalazine—Crohn's disease	0.00192	0.00301	CcSEcCtD
Goserelin—Alopecia—Azathioprine—Crohn's disease	0.0019	0.00298	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—TAGAP—Crohn's disease	0.0019	0.00524	CbGpPWpGaD
Goserelin—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00189	0.00296	CcSEcCtD
Goserelin—Ecchymosis—Prednisone—Crohn's disease	0.00187	0.00293	CcSEcCtD
Goserelin—GNRHR—GPCR ligand binding—PTGER4—Crohn's disease	0.00185	0.00512	CbGpPWpGaD
Goserelin—Eye disorder—Mesalazine—Crohn's disease	0.00183	0.00287	CcSEcCtD
Goserelin—Cardiac disorder—Mesalazine—Crohn's disease	0.00182	0.00285	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR9—Crohn's disease	0.0018	0.00496	CbGpPWpGaD
Goserelin—Sepsis—Prednisone—Crohn's disease	0.00179	0.00281	CcSEcCtD
Goserelin—Angiopathy—Mesalazine—Crohn's disease	0.00178	0.00279	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—CCR6—Crohn's disease	0.00178	0.00491	CbGpPWpGaD
Goserelin—Immune system disorder—Mesalazine—Crohn's disease	0.00177	0.00277	CcSEcCtD
Goserelin—Chills—Mesalazine—Crohn's disease	0.00176	0.00276	CcSEcCtD
Goserelin—Diarrhoea—Mercaptopurine—Crohn's disease	0.00176	0.00275	CcSEcCtD
Goserelin—Ill-defined disorder—Azathioprine—Crohn's disease	0.00174	0.00272	CcSEcCtD
Goserelin—Alopecia—Mesalazine—Crohn's disease	0.00173	0.00271	CcSEcCtD
Goserelin—Thrombophlebitis—Prednisone—Crohn's disease	0.00173	0.00271	CcSEcCtD
Goserelin—Anaemia—Azathioprine—Crohn's disease	0.00173	0.00271	CcSEcCtD
Goserelin—Diabetes mellitus—Prednisone—Crohn's disease	0.00172	0.0027	CcSEcCtD
Goserelin—Mental disorder—Mesalazine—Crohn's disease	0.00172	0.00269	CcSEcCtD
Goserelin—Erythema—Mesalazine—Crohn's disease	0.00171	0.00267	CcSEcCtD
Goserelin—Malaise—Azathioprine—Crohn's disease	0.00169	0.00265	CcSEcCtD
Goserelin—Flatulence—Mesalazine—Crohn's disease	0.00168	0.00263	CcSEcCtD
Goserelin—Leukopenia—Azathioprine—Crohn's disease	0.00168	0.00263	CcSEcCtD
Goserelin—Tension—Mesalazine—Crohn's disease	0.00167	0.00262	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—GPR65—Crohn's disease	0.00167	0.00461	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RSPO3—Crohn's disease	0.00166	0.00458	CbGpPWpGaD
Goserelin—Nervousness—Mesalazine—Crohn's disease	0.00166	0.0026	CcSEcCtD
Goserelin—Cardiac failure congestive—Prednisone—Crohn's disease	0.00165	0.00259	CcSEcCtD
Goserelin—Back pain—Mesalazine—Crohn's disease	0.00165	0.00259	CcSEcCtD
Goserelin—Muscle spasms—Mesalazine—Crohn's disease	0.00164	0.00257	CcSEcCtD
Goserelin—Vomiting—Mercaptopurine—Crohn's disease	0.00163	0.00256	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCR9—Crohn's disease	0.00163	0.0045	CbGpPWpGaD
Goserelin—Rash—Mercaptopurine—Crohn's disease	0.00162	0.00253	CcSEcCtD
Goserelin—Dermatitis—Mercaptopurine—Crohn's disease	0.00162	0.00253	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CCR6—Crohn's disease	0.00161	0.00446	CbGpPWpGaD
Goserelin—Vision blurred—Mesalazine—Crohn's disease	0.00161	0.00252	CcSEcCtD
Goserelin—Amnesia—Prednisone—Crohn's disease	0.0016	0.0025	CcSEcCtD
Goserelin—Increased appetite—Prednisone—Crohn's disease	0.0016	0.0025	CcSEcCtD
Goserelin—Myalgia—Azathioprine—Crohn's disease	0.00159	0.0025	CcSEcCtD
Goserelin—Arthralgia—Azathioprine—Crohn's disease	0.00159	0.0025	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.00158	0.00248	CcSEcCtD
Goserelin—Ill-defined disorder—Mesalazine—Crohn's disease	0.00158	0.00248	CcSEcCtD
Goserelin—Anaemia—Mesalazine—Crohn's disease	0.00158	0.00247	CcSEcCtD
Goserelin—Discomfort—Azathioprine—Crohn's disease	0.00158	0.00247	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SEL1L—Crohn's disease	0.00157	0.00435	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—PTGER4—Crohn's disease	0.00156	0.00432	CbGpPWpGaD
Goserelin—Malaise—Mesalazine—Crohn's disease	0.00154	0.00241	CcSEcCtD
Goserelin—Cardiac failure—Prednisone—Crohn's disease	0.00154	0.00241	CcSEcCtD
Goserelin—Lethargy—Prednisone—Crohn's disease	0.00153	0.0024	CcSEcCtD
Goserelin—Leukopenia—Mesalazine—Crohn's disease	0.00153	0.00239	CcSEcCtD
Goserelin—Nausea—Mercaptopurine—Crohn's disease	0.00152	0.00239	CcSEcCtD
Goserelin—Infection—Azathioprine—Crohn's disease	0.00152	0.00238	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—GPR65—Crohn's disease	0.00152	0.00419	CbGpPWpGaD
Goserelin—Palpitations—Mesalazine—Crohn's disease	0.00151	0.00236	CcSEcCtD
Goserelin—Osteoarthritis—Prednisone—Crohn's disease	0.0015	0.00235	CcSEcCtD
Goserelin—Thrombocytopenia—Azathioprine—Crohn's disease	0.0015	0.00235	CcSEcCtD
Goserelin—Cough—Mesalazine—Crohn's disease	0.00149	0.00233	CcSEcCtD
Goserelin—Skin disorder—Azathioprine—Crohn's disease	0.00148	0.00233	CcSEcCtD
Goserelin—Affect lability—Prednisone—Crohn's disease	0.00148	0.00231	CcSEcCtD
Goserelin—Hypertension—Mesalazine—Crohn's disease	0.00147	0.00231	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—ACKR2—Crohn's disease	0.00147	0.00405	CbGpPWpGaD
Goserelin—Psychotic disorder—Prednisone—Crohn's disease	0.00146	0.00229	CcSEcCtD
Goserelin—Myalgia—Mesalazine—Crohn's disease	0.00145	0.00228	CcSEcCtD
Goserelin—Arthralgia—Mesalazine—Crohn's disease	0.00145	0.00228	CcSEcCtD
Goserelin—Chest pain—Mesalazine—Crohn's disease	0.00145	0.00228	CcSEcCtD
Goserelin—Anxiety—Mesalazine—Crohn's disease	0.00145	0.00227	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00144	0.00226	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCR9—Crohn's disease	0.00144	0.00397	CbGpPWpGaD
Goserelin—Discomfort—Mesalazine—Crohn's disease	0.00143	0.00225	CcSEcCtD
Goserelin—Hypotension—Azathioprine—Crohn's disease	0.00143	0.00224	CcSEcCtD
Goserelin—Dry mouth—Mesalazine—Crohn's disease	0.00142	0.00223	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—PTGER4—Crohn's disease	0.00142	0.00392	CbGpPWpGaD
Goserelin—Mood swings—Prednisone—Crohn's disease	0.00142	0.00223	CcSEcCtD
Goserelin—Confusional state—Mesalazine—Crohn's disease	0.0014	0.0022	CcSEcCtD
Goserelin—Musculoskeletal discomfort—Azathioprine—Crohn's disease	0.00139	0.00218	CcSEcCtD
Goserelin—Anaphylactic shock—Mesalazine—Crohn's disease	0.00139	0.00218	CcSEcCtD
Goserelin—Oedema—Mesalazine—Crohn's disease	0.00139	0.00218	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—MLN—Crohn's disease	0.00139	0.00384	CbGpPWpGaD
Goserelin—Infection—Mesalazine—Crohn's disease	0.00138	0.00217	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—Crohn's disease	0.00138	0.00382	CbGpPWpGaD
Goserelin—Dry skin—Prednisone—Crohn's disease	0.00137	0.00215	CcSEcCtD
Goserelin—Shock—Mesalazine—Crohn's disease	0.00137	0.00215	CcSEcCtD
Goserelin—Nervous system disorder—Mesalazine—Crohn's disease	0.00137	0.00214	CcSEcCtD
Goserelin—Thrombocytopenia—Mesalazine—Crohn's disease	0.00136	0.00214	CcSEcCtD
Goserelin—Tachycardia—Mesalazine—Crohn's disease	0.00136	0.00213	CcSEcCtD
Goserelin—Skin disorder—Mesalazine—Crohn's disease	0.00135	0.00212	CcSEcCtD
Goserelin—Hyperhidrosis—Mesalazine—Crohn's disease	0.00135	0.00211	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—GPR65—Crohn's disease	0.00134	0.00369	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—IL3—Crohn's disease	0.00133	0.00368	CbGpPWpGaD
Goserelin—LHCGR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00133	0.00368	CbGpPWpGaD
Goserelin—Anorexia—Mesalazine—Crohn's disease	0.00133	0.00208	CcSEcCtD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—JAK2—Crohn's disease	0.00132	0.00364	CbGpPWpGaD
Goserelin—Hypotension—Mesalazine—Crohn's disease	0.0013	0.00204	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00129	0.00356	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TAGAP—Crohn's disease	0.00127	0.00351	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Mesalazine—Crohn's disease	0.00127	0.00199	CcSEcCtD
Goserelin—Feeling abnormal—Azathioprine—Crohn's disease	0.00126	0.00197	CcSEcCtD
Goserelin—Insomnia—Mesalazine—Crohn's disease	0.00126	0.00197	CcSEcCtD
Goserelin—Paraesthesia—Mesalazine—Crohn's disease	0.00125	0.00196	CcSEcCtD
Goserelin—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00125	0.00196	CcSEcCtD
Goserelin—Dyspnoea—Mesalazine—Crohn's disease	0.00124	0.00195	CcSEcCtD
Goserelin—Somnolence—Mesalazine—Crohn's disease	0.00124	0.00194	CcSEcCtD
Goserelin—Dyspepsia—Mesalazine—Crohn's disease	0.00123	0.00192	CcSEcCtD
Goserelin—Decreased appetite—Mesalazine—Crohn's disease	0.00121	0.0019	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL3—Crohn's disease	0.00121	0.00334	CbGpPWpGaD
Goserelin—Abdominal pain—Azathioprine—Crohn's disease	0.00121	0.00189	CcSEcCtD
Goserelin—Body temperature increased—Azathioprine—Crohn's disease	0.00121	0.00189	CcSEcCtD
Goserelin—Fatigue—Mesalazine—Crohn's disease	0.0012	0.00188	CcSEcCtD
Goserelin—Erectile dysfunction—Prednisone—Crohn's disease	0.00119	0.00187	CcSEcCtD
Goserelin—Constipation—Mesalazine—Crohn's disease	0.00119	0.00187	CcSEcCtD
Goserelin—Pain—Mesalazine—Crohn's disease	0.00119	0.00187	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—CCR6—Crohn's disease	0.00119	0.00329	CbGpPWpGaD
Goserelin—Weight increased—Prednisone—Crohn's disease	0.00118	0.00185	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—RASGRP1—Crohn's disease	0.00117	0.00323	CbGpPWpGaD
Goserelin—Hyperglycaemia—Prednisone—Crohn's disease	0.00117	0.00183	CcSEcCtD
Goserelin—Depression—Prednisone—Crohn's disease	0.00115	0.0018	CcSEcCtD
Goserelin—Feeling abnormal—Mesalazine—Crohn's disease	0.00115	0.0018	CcSEcCtD
Goserelin—Acute coronary syndrome—Prednisone—Crohn's disease	0.00114	0.00178	CcSEcCtD
Goserelin—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00114	0.00178	CcSEcCtD
Goserelin—Myocardial infarction—Prednisone—Crohn's disease	0.00113	0.00177	CcSEcCtD
Goserelin—Hypersensitivity—Azathioprine—Crohn's disease	0.00113	0.00176	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RSPO3—Crohn's disease	0.00111	0.00307	CbGpPWpGaD
Goserelin—Urticaria—Mesalazine—Crohn's disease	0.00111	0.00173	CcSEcCtD
Goserelin—Abdominal pain—Mesalazine—Crohn's disease	0.0011	0.00172	CcSEcCtD
Goserelin—Body temperature increased—Mesalazine—Crohn's disease	0.0011	0.00172	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—CCR6—Crohn's disease	0.00108	0.00298	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SEL1L—Crohn's disease	0.00105	0.00291	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—PTGER4—Crohn's disease	0.00105	0.00289	CbGpPWpGaD
Goserelin—Diarrhoea—Azathioprine—Crohn's disease	0.00105	0.00164	CcSEcCtD
Goserelin—Haemoglobin—Prednisone—Crohn's disease	0.00104	0.00163	CcSEcCtD
Goserelin—Haemorrhage—Prednisone—Crohn's disease	0.00104	0.00162	CcSEcCtD
Goserelin—Hypersensitivity—Mesalazine—Crohn's disease	0.00103	0.00161	CcSEcCtD
Goserelin—LHCGR—GPCR ligand binding—CXCL8—Crohn's disease	0.00101	0.0028	CbGpPWpGaD
Goserelin—Dizziness—Azathioprine—Crohn's disease	0.00101	0.00158	CcSEcCtD
Goserelin—Asthenia—Mesalazine—Crohn's disease	0.000999	0.00157	CcSEcCtD
Goserelin—Pruritus—Mesalazine—Crohn's disease	0.000985	0.00154	CcSEcCtD
Goserelin—Vomiting—Azathioprine—Crohn's disease	0.000972	0.00152	CcSEcCtD
Goserelin—Eye disorder—Prednisone—Crohn's disease	0.000969	0.00152	CcSEcCtD
Goserelin—Rash—Azathioprine—Crohn's disease	0.000964	0.00151	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR9—Crohn's disease	0.000963	0.00266	CbGpPWpGaD
Goserelin—Dermatitis—Azathioprine—Crohn's disease	0.000963	0.00151	CcSEcCtD
Goserelin—Headache—Azathioprine—Crohn's disease	0.000958	0.0015	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—CCR6—Crohn's disease	0.000953	0.00263	CbGpPWpGaD
Goserelin—Diarrhoea—Mesalazine—Crohn's disease	0.000953	0.00149	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—PTGER4—Crohn's disease	0.000951	0.00263	CbGpPWpGaD
Goserelin—Angiopathy—Prednisone—Crohn's disease	0.000941	0.00147	CcSEcCtD
Goserelin—Immune system disorder—Prednisone—Crohn's disease	0.000937	0.00147	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—IL2RA—Crohn's disease	0.000933	0.00258	CbGpPWpGaD
Goserelin—Arrhythmia—Prednisone—Crohn's disease	0.000926	0.00145	CcSEcCtD
Goserelin—Dizziness—Mesalazine—Crohn's disease	0.000921	0.00144	CcSEcCtD
Goserelin—Alopecia—Prednisone—Crohn's disease	0.000916	0.00144	CcSEcCtD
Goserelin—Mental disorder—Prednisone—Crohn's disease	0.000908	0.00142	CcSEcCtD
Goserelin—Nausea—Azathioprine—Crohn's disease	0.000908	0.00142	CcSEcCtD
Goserelin—Malnutrition—Prednisone—Crohn's disease	0.000903	0.00141	CcSEcCtD
Goserelin—Erythema—Prednisone—Crohn's disease	0.000903	0.00141	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—GPR65—Crohn's disease	0.000895	0.00247	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL3—Crohn's disease	0.000892	0.00246	CbGpPWpGaD
Goserelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00089	0.00246	CbGpPWpGaD
Goserelin—Vomiting—Mesalazine—Crohn's disease	0.000885	0.00139	CcSEcCtD
Goserelin—Rash—Mesalazine—Crohn's disease	0.000878	0.00138	CcSEcCtD
Goserelin—Dermatitis—Mesalazine—Crohn's disease	0.000877	0.00137	CcSEcCtD
Goserelin—Headache—Mesalazine—Crohn's disease	0.000872	0.00137	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000862	0.00238	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—RBX1—Crohn's disease	0.000862	0.00238	CbGpPWpGaD
Goserelin—Vision blurred—Prednisone—Crohn's disease	0.000851	0.00133	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—IL2RA—Crohn's disease	0.000847	0.00234	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—PTGER4—Crohn's disease	0.000839	0.00232	CbGpPWpGaD
Goserelin—Ill-defined disorder—Prednisone—Crohn's disease	0.000837	0.00131	CcSEcCtD
Goserelin—Anaemia—Prednisone—Crohn's disease	0.000834	0.00131	CcSEcCtD
Goserelin—Nausea—Mesalazine—Crohn's disease	0.000827	0.0013	CcSEcCtD
Goserelin—Malaise—Prednisone—Crohn's disease	0.000814	0.00128	CcSEcCtD
Goserelin—GNRHR—Signaling by GPCR—IL3—Crohn's disease	0.00081	0.00224	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—RASGRP1—Crohn's disease	0.000783	0.00216	CbGpPWpGaD
Goserelin—Convulsion—Prednisone—Crohn's disease	0.000782	0.00123	CcSEcCtD
Goserelin—Hypertension—Prednisone—Crohn's disease	0.000779	0.00122	CcSEcCtD
Goserelin—Myalgia—Prednisone—Crohn's disease	0.000768	0.0012	CcSEcCtD
Goserelin—Arthralgia—Prednisone—Crohn's disease	0.000768	0.0012	CcSEcCtD
Goserelin—Anxiety—Prednisone—Crohn's disease	0.000766	0.0012	CcSEcCtD
Goserelin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000763	0.0012	CcSEcCtD
Goserelin—Discomfort—Prednisone—Crohn's disease	0.000759	0.00119	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—UBE2D1—Crohn's disease	0.000756	0.00209	CbGpPWpGaD
Goserelin—Oedema—Prednisone—Crohn's disease	0.000737	0.00115	CcSEcCtD
Goserelin—Anaphylactic shock—Prednisone—Crohn's disease	0.000737	0.00115	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RIPK2—Crohn's disease	0.000733	0.00202	CbGpPWpGaD
Goserelin—Infection—Prednisone—Crohn's disease	0.000732	0.00115	CcSEcCtD
Goserelin—Shock—Prednisone—Crohn's disease	0.000725	0.00114	CcSEcCtD
Goserelin—Nervous system disorder—Prednisone—Crohn's disease	0.000722	0.00113	CcSEcCtD
Goserelin—Tachycardia—Prednisone—Crohn's disease	0.000719	0.00113	CcSEcCtD
Goserelin—Skin disorder—Prednisone—Crohn's disease	0.000715	0.00112	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL3—Crohn's disease	0.000715	0.00197	CbGpPWpGaD
Goserelin—Hyperhidrosis—Prednisone—Crohn's disease	0.000712	0.00112	CcSEcCtD
Goserelin—Anorexia—Prednisone—Crohn's disease	0.000702	0.0011	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—RASGRP1—Crohn's disease	0.000691	0.00191	CbGpPWpGaD
Goserelin—GNRHR—GPCR ligand binding—CXCL8—Crohn's disease	0.000678	0.00187	CbGpPWpGaD
Goserelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—Crohn's disease	0.000675	0.00187	CbGpPWpGaD
Goserelin—Musculoskeletal discomfort—Prednisone—Crohn's disease	0.000671	0.00105	CcSEcCtD
Goserelin—Insomnia—Prednisone—Crohn's disease	0.000666	0.00104	CcSEcCtD
Goserelin—Paraesthesia—Prednisone—Crohn's disease	0.000661	0.00104	CcSEcCtD
Goserelin—Dyspepsia—Prednisone—Crohn's disease	0.000648	0.00102	CcSEcCtD
Goserelin—Decreased appetite—Prednisone—Crohn's disease	0.00064	0.001	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—CCR6—Crohn's disease	0.000638	0.00176	CbGpPWpGaD
Goserelin—Fatigue—Prednisone—Crohn's disease	0.000635	0.000995	CcSEcCtD
Goserelin—Constipation—Prednisone—Crohn's disease	0.00063	0.000987	CcSEcCtD
Goserelin—LHCGR—GPCR downstream signaling—JAK2—Crohn's disease	0.000627	0.00173	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—SOCS1—Crohn's disease	0.000626	0.00173	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—IL2RA—Crohn's disease	0.000625	0.00173	CbGpPWpGaD
Goserelin—Feeling abnormal—Prednisone—Crohn's disease	0.000607	0.000951	CcSEcCtD
Goserelin—Gastrointestinal pain—Prednisone—Crohn's disease	0.000602	0.000944	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—TYK2—Crohn's disease	0.000597	0.00165	CbGpPWpGaD
Goserelin—Urticaria—Prednisone—Crohn's disease	0.000585	0.000917	CcSEcCtD
Goserelin—Abdominal pain—Prednisone—Crohn's disease	0.000582	0.000913	CcSEcCtD
Goserelin—Body temperature increased—Prednisone—Crohn's disease	0.000582	0.000913	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RBX1—Crohn's disease	0.000577	0.00159	CbGpPWpGaD
Goserelin—LHCGR—GPCR downstream signaling—CXCL8—Crohn's disease	0.000572	0.00158	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—JAK2—Crohn's disease	0.00057	0.00157	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL2RA—Crohn's disease	0.000567	0.00157	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—PTGER4—Crohn's disease	0.000562	0.00155	CbGpPWpGaD
Goserelin—Hypersensitivity—Prednisone—Crohn's disease	0.000543	0.000851	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—SMAD3—Crohn's disease	0.000541	0.00149	CbGpPWpGaD
Goserelin—Asthenia—Prednisone—Crohn's disease	0.000529	0.000828	CcSEcCtD
Goserelin—Pruritus—Prednisone—Crohn's disease	0.000521	0.000817	CcSEcCtD
Goserelin—LHCGR—Signaling by GPCR—CXCL8—Crohn's disease	0.00052	0.00144	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—UBE2D1—Crohn's disease	0.000506	0.0014	CbGpPWpGaD
Goserelin—Diarrhoea—Prednisone—Crohn's disease	0.000504	0.00079	CcSEcCtD
Goserelin—LHCGR—Signaling Pathways—IL2RA—Crohn's disease	0.000501	0.00138	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—RIPK2—Crohn's disease	0.000491	0.00136	CbGpPWpGaD
Goserelin—Dizziness—Prednisone—Crohn's disease	0.000487	0.000763	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—IL3—Crohn's disease	0.000478	0.00132	CbGpPWpGaD
Goserelin—Vomiting—Prednisone—Crohn's disease	0.000468	0.000734	CcSEcCtD
Goserelin—Rash—Prednisone—Crohn's disease	0.000464	0.000728	CcSEcCtD
Goserelin—Dermatitis—Prednisone—Crohn's disease	0.000464	0.000727	CcSEcCtD
Goserelin—GNRHR—Signaling Pathways—RASGRP1—Crohn's disease	0.000463	0.00128	CbGpPWpGaD
Goserelin—Headache—Prednisone—Crohn's disease	0.000461	0.000723	CcSEcCtD
Goserelin—Nausea—Prednisone—Crohn's disease	0.000438	0.000686	CcSEcCtD
Goserelin—GNRHR—GPCR downstream signaling—JAK2—Crohn's disease	0.00042	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SOCS1—Crohn's disease	0.000419	0.00116	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—TYK2—Crohn's disease	0.0004	0.0011	CbGpPWpGaD
Goserelin—GNRHR—GPCR downstream signaling—CXCL8—Crohn's disease	0.000383	0.00106	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—JAK2—Crohn's disease	0.000381	0.00105	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—SMAD3—Crohn's disease	0.000362	0.001	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—TYK2—Crohn's disease	0.000353	0.000974	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—CXCL8—Crohn's disease	0.000348	0.000961	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—JAK2—Crohn's disease	0.000336	0.00093	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL2RA—Crohn's disease	0.000335	0.000926	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—CXCL8—Crohn's disease	0.000307	0.000848	CbGpPWpGaD
Goserelin—LHCGR—Signaling by GPCR—IL6—Crohn's disease	0.000292	0.000807	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—STAT3—Crohn's disease	0.000247	0.000682	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—TYK2—Crohn's disease	0.000236	0.000652	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—JAK2—Crohn's disease	0.000225	0.000622	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—CXCL8—Crohn's disease	0.000206	0.000568	CbGpPWpGaD
Goserelin—GNRHR—Signaling by GPCR—IL6—Crohn's disease	0.000195	0.00054	CbGpPWpGaD
Goserelin—LHCGR—Signaling Pathways—IL6—Crohn's disease	0.000172	0.000477	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—STAT3—Crohn's disease	0.000165	0.000457	CbGpPWpGaD
Goserelin—GNRHR—Signaling Pathways—IL6—Crohn's disease	0.000115	0.000319	CbGpPWpGaD
